AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS)

CUSIP: 05350V106

Q3 2025 13F Holders as of 30 Sep 2025

Security identity
Shares outstanding
46,511,628
Holder snapshot
Share change
+174,093
Reported price per share
$11.56
Number of holders
269
Value change
-$456,743
Number of buys
128
Number of sells
119

Security key

05350V106

Report period

Q3 2025

Institutions

269

Top holders

10

Ownership snapshot

Top reported holders of AVNS - AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
BlackRock, Inc.
13D/G signal
BlackRock, Inc.
Evidence rows
15
Latest as of
30 Jun 2025
13D/G 13F 3/4/5 Lead comparable stake: 15% 13D/G row: BlackRock, Inc. Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock, Inc.
13D/G 13F
Company
15%
$84,305,460
6,826,353 shares
$0 31 Mar 2025
Jason Pickett Power
3/4/5
Interim CFO and Treasurer
0.09%
$574,823
40,113 shares
14 Apr 2025
VANGUARD GROUP INC
13F
Company
13F
9.6%
$54,650,327
4,464,896 shares
30 Jun 2025
T. Rowe Price Investment Management, Inc.
13F
Company
13F
8.6%
$48,918,000
3,996,518 shares
30 Jun 2025
DIMENSIONAL FUND ADVISORS LP
13F
Company
13F
5.5%
$31,555,557
2,578,064 shares
30 Jun 2025
ARMISTICE CAPITAL, LLC
13F
Company
13F
4.4%
$24,920,640
2,036,000 shares
30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
269
Shares
44,915,629
Rows available
269
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
279
Q3 2025 holders
269
Holder diff
-10
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .